Evaluation of bleeding adverse events associated with oral P2Y12 inhibitors use in the Food and Drug Administration adverse event reporting system

P2Y12 inhibitors show different bleeding-related safety profiles in premarketing trials. However, little is known about their potential safety from spontaneous reporting systems and postmarketing data. To describe and evaluate the bleeding-related adverse events associated with use of P2Y12 inhibito...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of clinical pharmacology and therapeutics
Main Authors Fahmy, Ahmed I, Mekkawy, Mohamed A, Abou-Ali, Adel
Format Journal Article
LanguageEnglish
Published Germany 10.02.2019
Online AccessGet full text

Cover

Loading…